Options for Patients with Polycythemia Vera

Ruben A. Mesa, MD

Video Categories: Polycythemia Vera

Hear Dr. Mesa discuss options available for individual patients who have failed hydroxyurea polycythemia vera.

Supported through funding from Incyte
July 29, 2015

Personalized Medicine’s Impact on Cancer Care

Dr. Jorge Cortes provides examples of how personalized or precision medicine has positively impacted the approach to cancer care, citing the benefits of FLT3 inhibitors, IDH inhibitors, and MEK inhibitors, and other targeted treatments.

January 10, 2019

Dealing with Misinformation

Dr Morganna Freeman addresses the issue of the pervasiveness of misinformation on the Internet.